Apr 2, 2026 08:45AM RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference

Mar 11, 2026 07:24AM 60 Degrees Pharmaceuticals reports babesiosis cures in small trial

Feb 27, 2026 09:00AM 60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Feb 2, 2026 08:03AM 60 Degrees Pharmaceuticals partners with GoodRx for ARAKODA discounts

Jan 28, 2026 08:02AM 60 Degrees Pharmaceuticals exercises license option for castanospermine

Jan 22, 2026 08:03AM 60 Degrees Pharmaceuticals partners with Runway Health for malaria drug

Dec 29, 2025 08:02AM 60 Degrees Pharmaceuticals finds Babesia in 24% of chronic fatigue patients

Dec 26, 2025 09:00AM Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Dec 11, 2025 08:02AM 60 Degrees Pharmaceuticals plans ARAKODA sales expansion for 2026

Nov 21, 2025 08:01AM 60 Degrees Pharmaceuticals opens site for chronic babesiosis study

Nov 14, 2025 06:48AM H.C. Wainwright Assumes 60 Degrees Pharmaceuticals Inc (SXTP) at Buy

Oct 31, 2025 09:00AM 60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Oct 15, 2025 07:14AM 60 Degrees Pharmaceuticals reports first patient clears babesia infection

Oct 9, 2025 07:05AM 60 Degrees Pharmaceuticals names chronic babesiosis trial B-FREE

Oct 2, 2025 09:00AM Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22

Sep 19, 2025 09:00AM Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Aug 19, 2025 08:54AM 60 Degrees Pharmaceuticals picks Mount Sinai for babesiosis trial

Aug 8, 2025 09:00AM Aptevo Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Jul 17, 2025 08:01AM 60 Degrees Pharmaceuticals partners with Tulane to study lyme treatment

Jul 15, 2025 07:02AM 60 Degrees Pharmaceuticals estimates $245M annual market for babesiosis drug

Jul 14, 2025 04:01PM 60 Degrees Pharmaceuticals plans FDA submission for canine babesiosis drug

Jun 6, 2025 09:00AM 60 Degrees Pharmaceuticals and Liberty Star Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Jun 4, 2025 08:57AM 60 Degrees Pharmaceuticals (SXTP) Expands Options for Malaria Prevention with Introduction of ARAKODA 8-Count Bottle Format

Jun 2, 2025 05:13AM 60 Degrees Pharmaceuticals Inc (SXTP) PT Lowered to $7 at Ascendiant Capital

Apr 8, 2025 08:31AM 60 Degrees Pharmaceuticals (SXTP) Announces Patent License Agreement to Advance Development of Tafenoquine

Feb 21, 2025 09:00AM 60 Degrees Pharmaceuticals and Fathom Holdings Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Feb 20, 2025 10:36AM 60 Degrees Pharmaceuticals (SXTP) Announces 1:5 Reverse Stock Split

Feb 11, 2025 12:59PM 60 Degrees Pharmaceuticals (SXTP) to Import Limited Quantity of KODATEF

Feb 5, 2025 09:23AM 60 Degrees Pharmaceuticals (SXTP) Announces 1.5M Share Offering at $0.715/sh

Feb 3, 2025 08:30AM RedChip Launches RedChat: Revolutionary AI Chatbot for Small-Cap Stock Analysis

Jan 29, 2025 08:02AM 60 Degrees Pharmaceuticals (SXTP) Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jan 28, 2025 08:01AM 60 Degrees Pharmaceuticals (SXTP) Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis

Dec 24, 2024 06:54AM H.C. Wainwright Reiterates Neutral Rating on 60 Degrees Pharmaceuticals Inc (SXTP)

Dec 23, 2024 08:57AM 60 Degrees Pharmaceuticals (SXTP) and Tufts Medical Center Announce Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention

Dec 12, 2024 06:49AM H.C. Wainwright Reiterates Neutral Rating on 60 Degrees Pharmaceuticals Inc (SXTP)

Dec 11, 2024 08:56AM 60 Degrees Pharmaceuticals (SXTP) Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women’s Hospital

Dec 2, 2024 04:05PM VSee Health and 60 Degrees Pharmaceuticals Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Nov 22, 2024 09:00AM 60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Oct 3, 2024 09:02AM 60 Degrees Pharmaceuticals (SXTP) Announces ARAKODA Promotional Pilot in Advance of Expanded U.S. Launch

Sep 4, 2024 08:01AM 60 Degrees Pharmaceuticals (SXTP) Announces 2.9M Share Offering at $1.38/sh

Aug 28, 2024 02:51PM 60 Degrees Pharmaceuticals (SXTP) Regains Nasdaq Compliance

Aug 14, 2024 11:01AM 60 Degrees Pharmaceuticals (SXTP) Reports Q2 Results

Aug 12, 2024 09:12AM 60 Degrees Pharmaceuticals (SXTP) Provides University of Kentucky with Right of Reference to ARAKODA NDA in Support of SJ733 Phase IIb Study

Aug 6, 2024 09:26AM 60 Degrees Pharmaceuticals (SXTP) Announces 1:12 Reverse Share Split

Jul 25, 2024 09:03AM 60 Degrees Pharmaceuticals (SXTP) Wins Contract with U.S. Army for ARAKODA Supply Chain Upgrade Support

Jul 19, 2024 08:29AM 60 Degrees Pharmaceuticals (SXTP) Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study

Jul 12, 2024 05:07PM 60 Degrees Pharmaceuticals (SXTP) Files $15M Mixed Shelf

Jul 9, 2024 06:31AM 60 Degrees Pharmaceuticals (SXTP) Announces IRB Approval of Clinical Study of Tafenoquine

Jun 11, 2024 07:59AM 60 Degrees Pharmaceuticals (SXTP) Granted FDA Orphan Drug Designation for Tafenoquine